For people who smoke, early stage melanomas are more likely to become deadly

Publicly released:
Australia; International; QLD
Attribution: Melanoma Institute Australia
Attribution: Melanoma Institute Australia

People with stage I and II melanoma who smoke are at higher risk of dying from their melanoma than those who don't smoke or who have already quit, according to Australian research. The study found that patients who smoked at the time of melanoma diagnosis had a significantly increased risk of death due to melanoma, with some having doubled risk of  death from melanoma.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference:
JAMA Network Open
Research:Paper
Organisation/s: Melanoma Institute Australia, Saint John’s Cancer Institute, USA
Funder: This study was supported by grants CA189163 and CA29605 from the National Cancer Institute, theAmyx Foundation Inc, the Borstein Family Foundation, the Dr Miriam and Sheldon G. Adelson Medical Research Foundation, the JohnWayne Cancer Institute Auxiliary, a fellowship from the Tarble Foundation (Dr Jackson), and a Ruth and Martin H.Weil fellowship (Dr Fluke).
Media Contact/s
Contact details are only visible to registered journalists.